1. Home
  2. MAGN vs EBS Comparison

MAGN vs EBS Comparison

Compare MAGN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$12.63

Market Cap

437.2M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.37

Market Cap

423.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAGN
EBS
Founded
1864
1998
Country
United States
United States
Employees
8500
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.2M
423.6M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
MAGN
EBS
Price
$12.63
$8.37
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$12.00
AVG Volume (30 Days)
308.5K
743.9K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
0.07
Revenue
N/A
$742,900,000.00
Revenue This Year
$5.37
$1.29
Revenue Next Year
$3.47
N/A
P/E Ratio
N/A
$119.86
Revenue Growth
N/A
N/A
52 Week Low
$7.82
$5.62
52 Week High
$15.52
$14.06

Technical Indicators

Market Signals
Indicator
MAGN
EBS
Relative Strength Index (RSI) 69.80 49.58
Support Level $9.73 $7.76
Resistance Level $12.92 $8.78
Average True Range (ATR) 0.45 0.46
MACD 0.13 -0.02
Stochastic Oscillator 90.79 44.29

Price Performance

Historical Comparison
MAGN
EBS

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: